DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE

[1]  J. Hirsh,et al.  Catalysis of Thrombin Inhibition Provides an Index for Estimating the Antithrombotic Potential of Glycosaminoglycans in Rabbits , 1987, Thrombosis and Haemostasis.

[2]  J. Hirsh,et al.  A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. , 1986, The New England journal of medicine.

[3]  J. Hirsh,et al.  Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect. , 1986, Thrombosis research.

[4]  V. Kakkar,et al.  Efficacy and safety of low‐molecular‐weight heparin (CY216) in preventing postoperative venous thrombo‐embolism: A co‐operative study , 1985, The British journal of surgery.

[5]  J. O'brien.  The Heparin-Mobilisable Pool of Platelet Factor 4 and Thrombogenesis , 1985, Thrombosis and Haemostasis.

[6]  J. Hirsh,et al.  Rationale Behind the Development of Low Molecular Weight Heparin Derivatives , 1985, Seminars in thrombosis and hemostasis.

[7]  H. Büller,et al.  Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease , 1984, Annals of neurology.

[8]  H. Cate,et al.  USE OF A NEW HEPARINOID AS ANTICOAGULANT DURING ACUTE HAEMODIALYSIS OF PATIENTS WITH BLEEDING COMPLICATIONS , 1983, The Lancet.

[9]  D. Meuleman,et al.  A novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: a survey of its pharmacological properties in experimental animal models. , 1982, Thrombosis research.

[10]  T. Barrowcliffe,et al.  Effects of Heparin Oligosaccharides with High Affinity for Antithrombin III in Experimental Venous Thrombosis , 1982, Thrombosis and Haemostasis.

[11]  M. Gent,et al.  The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. , 1982, Blood.

[12]  D. Kleinbaum,et al.  Applied Regression Analysis and Other Multivariate Methods , 1978 .

[13]  C. Hawkey,et al.  LOW-DOSE HEPARIN AS A PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER ACUTE STROKE , 1977, The Lancet.

[14]  M. Lie,et al.  Assay of heparin in plasma using a chromogenic substrate for activated factor X. , 1976, Thrombosis research.

[15]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[16]  M. Brown,et al.  Mortality factors in patients with acute stroke. , 1973, JAMA.

[17]  C. Warlow,et al.  Venous thrombosis following strokes. , 1972, Lancet.

[18]  K. Rabinov,et al.  Roentgen diagnosis of venous thrombosis in the leg. , 1972, Archives of surgery.

[19]  D. Sackett,et al.  The value of adding impedance plethysmography to 125I-fibrinogen leg scanning for the detection of deep vein thrombosis in high risk surgical patients: a comparative study between patients undergoing general surgery and hip surgery. , 1979, Thrombosis research.

[20]  E. Salzman.  Prevention of Venous Thromboembolism , 1979, Thrombosis and Haemostasis.